Physiologically-Based PK Modeling (PBPK) & Systems Pharmacology Software Directory

Physiologically-Based PK Modeling (PBPK) and Systems Pharmacology platforms encode anatomy, physiology, and biological pathways as mechanistic models, allowing teams to project drug exposure and effect into populations or scenarios where clinical data is sparse or absent. The category sits at the intersection of pre-clinical translation, clinical pharmacology, and regulatory strategy — used by modeling and simulation groups to justify first-in-human doses, defend pediatric extrapolations, assess drug-drug interaction liability, and support organ-impairment labeling. Operational constraints are real: model qualification cycles are long, physiological parameter libraries must stay current with literature, and outputs that feed regulatory submissions need traceable provenance back to source assumptions.

The deployment pattern in this category is distinctive: the majority of tools are installed on-premise, reflecting both the sensitivity of compound-level inputs and the compute footprint of large virtual population runs. Open-source options remain a small minority, and AI or machine-learning augmentation appears in roughly a quarter of platforms — typically for parameter estimation or surrogate modeling rather than replacing mechanistic structure. Persona coverage skews heavily toward research scientists and computational scientists, with regulatory affairs involvement on around half of the tools, consistent with the category's frequent appearance in submission packages.